Author:
Kirchheiner J,Schmidt H,Tzvetkov M,Keulen J-Tha,Lötsch J,Roots I,Brockmöller J
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference37 articles.
1. Dayer P, Desmeules J, Leemann T, Striberni R . Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI). Biochem Biophys Res Commun 1988; 152: 411–416.
2. Yue QY, Alm C, Svensson JO, Sawe J . Quantification of the O- and N-demethylated and the glucuronidated metabolites of codeine relative to the debrisoquine metabolic ratio in urine in ultrarapid, rapid, and poor debrisoquine hydroxylators. Ther Drug Monit 1997; 19: 539–542.
3. Johansson I, Yue QY, Dahl ML, Heim M, Sawe J, Bertilsson L et al. Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine. Eur J Clin Pharmacol 1991; 40: 553–556.
4. Mortimer O, Persson K, Ladona MG, Spalding D, Zanger UM, Meyer UA et al. Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1. Clin Pharmacol Ther 1990; 47: 27–35.
5. Mikus G, Bochner F, Eichelbaum M, Horak P, Somogyi AA, Spector S . Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 (debrisoquine/sparteine) polymorphism. J Pharmacol Exp Ther 1994; 268: 546–551.
Cited by
347 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献